Related Experiment Video
Updated: Apr 27, 2026

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles
Published on: August 28, 2015
Polymeric micelles loaded with platinum anticancer drugs target preangiogenic micrometastatic niches associated with
Hailiang Wu1, Horacio Cabral1, Kazuko Toh2
1Department of Bioengineering, Graduate School of Engineering, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8656, Japan.
Abstract:
Nanocarriers have been used for specific delivery of therapeutic agents to solid tumors based on the enhanced permeability and retention in cancerous tissues. Despite metastasis is the main reason of cancer-related death and a priority for nanocarrier-based therapies, the targeting ability of nanocarriers to the metastatic disease is poorly understood, especially for preangiogenic micrometastases as nanocarriers usually use the malignant neovasculature for enhancing their accumulation. Thus, herein, we studied the ability of micellar nanocarriers incorporating (1,2-diaminocyclohexane)platinum(II) (DACHPt) for treating liver metastases of bioluminescent murine colon adenocarcinoma C-26, during overt and preangiogenic metastatic stages. After intravenous injection, DACHPt-loaded micelles (DACHPt/m) effectively inhibited the tumor growth in both metastatic tumor models. While the anticancer activity of the micelles against overt metastases was associated with their selective accumulation in cancerous tissues having neovasculature, the ability of DACHPt/m to target preangiogenic metastases was correlated with the inflammatory microenvironment of the niche. This targeting capability of polymeric micelles to preangiogenic metastasis may provide a novel approach for early diagnosis and treatment of metastases.
Insights
Polymeric micelles loaded with (1,2-diaminocyclohexane)platinum(II) (DACHPt) effectively treated liver metastases. These nanocarriers targeted both overt and preangiogenic metastases by exploiting tumor neovasculature and inflammatory microenvironments, respectively.
Area of Science:
- Oncology
- Materials Science
- Pharmacology
Background:
- Nanocarriers enhance drug delivery to solid tumors via the enhanced permeability and retention (EPR) effect.
- Metastasis is a primary cause of cancer mortality, yet nanocarrier targeting of early-stage, preangiogenic micrometastases remains poorly understood.
- Conventional nanocarriers rely on tumor neovasculature for accumulation, limiting their efficacy against nascent metastatic sites.
Purpose of the Study:
- To investigate the efficacy of micellar nanocarriers loaded with (1,2-diaminocyclohexane)platinum(II) (DACHPt) for treating liver metastases.
- To evaluate the targeting mechanisms of these nanocarriers in both overt and preangiogenic metastatic stages.
- To explore the potential of nanocarriers for early detection and treatment of metastatic disease.
Main Methods:
- Development of micellar nanocarriers encapsulating DACHPt (DACHPt/m).
- Intravenous administration of DACHPt/m in a murine colon adenocarcinoma (C-26) liver metastasis model.
- Assessment of tumor growth inhibition and nanocarrier accumulation in both overt and preangiogenic metastatic stages.
- Analysis of the correlation between nanocarrier targeting and tumor microenvironment characteristics.
Main Results:
- DACHPt/m significantly inhibited tumor growth in both overt and preangiogenic liver metastasis models.
- Targeting of overt metastases was attributed to selective accumulation in neovasculature-rich cancerous tissues.
- Targeting of preangiogenic metastases was linked to the inflammatory microenvironment of the metastatic niche.
- Demonstrated nanocarrier accumulation and therapeutic effect in early-stage metastatic lesions.
Conclusions:
- Polymeric micelles loaded with DACHPt are effective against liver metastases at different stages of development.
- Nanocarrier targeting mechanisms differ between overt (neovasculature-dependent) and preangiogenic (inflammatory microenvironment-dependent) metastases.
- This study highlights a novel strategy for targeting preangiogenic micrometastases, potentially enabling earlier diagnosis and treatment of cancer spread.
Related Concept Videos
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Drugs that Stabilize Microtubules
Targeted Cancer Therapies
There are several types of targeted therapies against...
The Tumor Microenvironment
Drugs that Destabilize Microtubules

